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Abstract 
Although the mechanisms by which mutant huntingtin (mHtt) results in Huntington’s disease 
(HD) remain unclear, mHtt-induced mitochondrial defects were implicated in HD 
pathogenesis. The effect of mHtt could be mediated by transcriptional alterations, by direct 
interaction with mitochondria, or by both. In the present study, we tested a hypothesis that 
mHtt directly damages mitochondria.  To test this hypothesis, we applied brain cytosolic 
fraction from YAC128 mice, containing mHtt, to brain nonsynaptic and synaptic 
mitochondria from wild-type (WT) mice and assessed mitochondrial respiration with a Clark-
type oxygen electrode, membrane potential and Ca
2+
 uptake capacity with 
tetraphenylphosphonium (TPP
+
)- and Ca
2+
-sensitive electrodes, respectively, and, ROS 
production with Amplex Red assay. The amount of mHtt bound to mitochondria following 
incubation with mHtt-containing cytosolic fraction was greater than the amount of mHtt 
bound to brain mitochondria isolated from YAC128 mice. Despite mHtt binding to WT 
mitochondria, no abnormalities in mitochondrial functions were detected. This is consistent 
with our previous results demonstrating the lack of defects in brain mitochondria isolated 
from R6/2 and YAC128 mice. This, however, could be due to partial loss of mitochondrially 
bound mHtt during the isolation procedure. Consequently, we increased the amount of 
mitochondrially bound mHtt by incubating brain nonsynaptic and synaptic mitochondria 
isolated from YAC128 mice with mHtt-containing cytosolic fraction. Despite enrichment of 
YAC128 brain mitochondria with mHtt, mitochondrial functions (respiration, membrane 
potential, ROS production, Ca
2+
 uptake capacity) remained unchanged. Overall, our results 
suggest that mHtt does not directly impair mitochondrial functions, arguing against the 
involvement of this mechanism in HD pathogenesis.      
 
INTRODUCTION 
Huntington’s disease (HD) is a fatal hereditary neurodegenerative disorder that is 
characterized by progressively declining motor and cognitive capabilities. HD is linked to a 
mutation in a single gene encoding the huntingtin protein (Htt), a 350 kDa protein that, when 
mutated, contains an elongated poly-glutamine (polyQ) stretch at a site near the N-terminus 
(MacDonald et al. 1993). In healthy individuals, the polyQ tract in Htt contains less than 35 
glutamines (Bates et al. 2015).  In HD patients, the mutant huntingtin protein (mHtt) with 
pathologically expanded polyQ stretch leads to striatal and cortical degeneration, and 
subsequently to HD progression and development of HD symptoms. Despite the 
identification of the genetic mutation linked to HD, the mechanisms by which mHtt exerts its 
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harmful effects are not clear. However, bioenergetic abnormalities, augmented reactive 
oxygen species (ROS) production, and defects in mitochondrial Ca
2+
 handling have been 
implicated as possible factors contributing to HD pathogenesis.   
 
It has been previously suggested that there might be aberrations in mitochondrial respiration 
and abnormalities in Ca
2+
 handling in mitochondria from HD mice and HD cell models 
(Tabrizi et al. 2000;Panov et al. 2002;Choo et al. 2004;Fernandes et al. 2007;Lim et al. 
2008;Kim et al. 2011;Aidt et al. 2013;Damiano et al. 2013). However, in our previous 
studies, we did not find any evidence for deleterious effects of mHtt on Ca
2+ 
handling or 
oxidative metabolism in brain mitochondria isolated from R6/2 or YAC128 mice (Hamilton 
et al. 2015;Pellman et al. 2015;Hamilton et al. 2016;Hamilton et al. 2017). Wild-type as well 
as mutant Htt interact with the outer mitochondrial membrane and are not transported into 
mitochondria (Choo et al. 2004;Orr et al. 2008). Consistent with previous reports (Choo et al. 
2004;Orr et al. 2008), we showed that mHtt remains attached to mitochondria during the 
isolation procedure, but whether the remaining attached mHtt is sufficient for inducing 
mitochondrial defects was not clear. It was possible that some mHtt was washed out from the 
mitochondria during the isolation procedure and this might explain the lack of mitochondrial 
defects in our previous experiments (Hamilton et al. 2015;Pellman et al. 2015;Hamilton et al. 
2016;Hamilton et al. 2017). It was also unclear whether mitochondria from HD mice are 
predisposed to mHtt-induced impairment or whether mHtt could acutely damage 
mitochondria from WT animals. 
 
The two major objectives of the current study were to test (i) whether mHtt can directly 
damage WT mitochondria and (ii) whether enrichment of HD mitochondria with mHtt will 
result in detectable mitochondrial defects. In the present study, we assessed respiration, 
membrane potential, ROS production, and Ca
2+ 
handling of brain mitochondria isolated from 
YAC128 and WT mice following acute application of concentrated cytosolic fraction 
containing mHtt. We found that despite mHtt association with isolated WT mitochondria, 
there were no abnormalities in mitochondrial respiration, membrane potential, ROS 
production, or Ca
2+
 uptake capacity. Acute application of mHtt to brain mitochondria isolated 
from YAC128 mice increased the total amount of mHtt bound to mitochondria, but failed to 
degrade mitochondrial functions. Consequently, consistent with results from our previous 
studies, we found no evidence to suggest that mHtt directly and acutely damages 
mitochondria.       
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MATERIALS and METHODS 
Materials 
Pyruvate, malate, ethylene glycol tetraacetic acid (EGTA; Cat# E4378), ADP (Cat# A5285), 
oligomycin (Cat# 75351) and 2,4-dinitrophenol (Cat# D198501) were purchased from Sigma 
(St. Louis, MO, USA). Tetraphenylphosphonium chloride (Cat# 88060) was from Fluka 
(Buchs, Switzerland). Percoll (Cat# 17089101) was from GE Healthcare Bio-Sciences 
(Pittsburgh, PA, USA). Bovine serum albumin (BSA), free from free fatty acids (Cat# 
152401), was from MP Biomedicals (Irvine, CA, USA). All materials were purchased no 
more than 6 months before use. 
 
Animals 
All procedures with animals were performed in accordance with the Indiana University 
School of Medicine Institutional Animal Care and Use Committee approved protocol (# 
11385 MD/R). The study was not pre-registered. No randomization was performed to allocate 
mice in the study. Wild-type FVB/NJ (RRID: IMSR_JAX:001800) mice and transgenic HD 
YAC128 (RRID: IMSR_JAX:004938) mice of both sexes were used in this study. Breeding 
pairs of mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) and 
breeding colonies were established in the Laboratory Animals Research Center (LARC) at 
Indiana University School of Medicine, Indianapolis, IN, USA. Male YAC128 mice were 
bred with female FVB/NJ mice (background strain). Every mouse was genotyped and 
weighed 19-25g at 2-4 months of age. The mice were housed under standard conditions with 
free access to food and water. All mice were housed in polycarbonate cages, 3 mice per cage. 
For our experiments, we used 2-4-month-old YAC128 mice and their wild-type (WT) 
littermates. Sixty-three FVB/NJ mice and 66 YAC128 mice were used in our study; we used 
all animals initially taken in the experiment and did not exclude any animal from our study. 
The total number of animals used in this study was 129. There is evidence that sex hormones 
may influence mitochondrial functions (Gaignard et al. 2017). However, HD affects men and 
women equally (Novak and Tabrizi 2010;World Health Organization 2016). Therefore, 
throughout this study, mice of both sexes were used. Mitochondria from male and female WT 
and YAC128 mice were used simultaneously in experiments. YAC128 mice express full-
length human mHtt, including upstream and downstream regulatory elements, containing a 
polyglutamine (polyQ) region of 128 glutamines. In our study, one investigator was 
responsible for maintaining the breeding colonies of YAC128 and FVB/NJ mice, preparing 
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cytosolic fractions, and isolating mitochondria. Then, another investigator conducted the 
experiments with these fractions and mitochondria without knowing the identity of these 
materials. Data were analyzed only by the investigator who conducted the experiments. 
 
Genotyping 
All offspring used for experiments were genotyped using a PCR assay on tail DNA. PCR of 
tail DNA was performed according to the protocol provided by Jackson Laboratories with 
oligonucleotide primers oIMR6533 (GGCTGAGGAAGCTGAGGAG) and TmoIMR1594 
(CCGCTCAGGTTCTGCTTTTA) (Invitrogen, Carlsbad, CA, USA). The PCR reaction 
mixture consisted of 1μl DNA template and 24μl Platinum PCR SuperMix (Invitrogen; Cat# 
12532024) containing 0.39μM of each primer (Invitrogen) for a total volume of 25μl. Cycling 
conditions were 5 min at 95°C, and then 35 cycles of 30 s at 95°C, 30 s at 56°C, 60 s at 72°C, 
followed by 10 min at 72°C. Reaction products were visualized on a 1.2% agarose gel run at 
100 V for 60 min with Tris-acetate-EDTA running buffer containing 1X GelRed™ Nucleic 
Acid Gel Stain (Biotium, Hayward, CA, USA; Cat# 41003). 
 
Isolation of brain nonsynaptic and synaptic mitochondria 
Percoll gradient-purified brain nonsynaptic and synaptic mitochondria from 2-4-month-old 
YAC128 and age-matched wild-type FVB/NJ littermates were isolated as we described 
previously with some modifications (Sims 1990;Brustovetsky and Brustovetsky 2017). 
Briefly, unanesthetized mice were euthanized by rapid decapitation using a sharp guillotine, 
which is an acceptable method for small rodents approved by American Veterinary Medical 
Association 2013 Guidelines. All procedures using animals were acute, and the animals 
experienced no pain. Administration of anesthesia impairs key mitochondrial enzymes 
(Brunner et al., 1975; Nahrwold and Cohen, 1975; Cohen, 1973; Lenaz et al., 1978). 
Therefore, in order to study mitochondrial respiration, membrane potential, ROS production, 
and mitochondrial Ca
2+
 uptake, mitochondria were prepared from unanesthetized animals. To 
prepare nonsynaptic and synaptic mitochondria, brains of three FVB/NJ and YAC128 mice 
each were used for a single isolation procedure.  After brain tissue was homogenized in a 15 
ml glass Dounce homogenizer (10 strokes with pestle A, 30 strokes with pestle B) on ice, 
homogenate was diluted with 30 ml of Isolation Buffer 1 and centrifuged for 10 minutes at 
2,400 rpm in a Beckman Avanti J-26XP centrifuge, rotor JA-25.50 (700×g). All procedures 
were performed at 2-4ºC.  After the 1
st
 centrifugation, supernate was centrifuged for 10 
minutes at 12,500 rpm (18,900×g) in a Beckman Avanti J-26XP centrifuge, rotor JA-25.50.  
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Supernate (cytosolic fraction) was set aside to be concentrated later, and the pellet was 
resuspended in 35 ml of Isolation Buffer 1 and centrifuged for 10 minutes at 12,500 rpm 
(18,900×g) in a Beckman Avanti J-26XP centrifuge, rotor JA-25.50.  Then, the pellet was 
resuspended in 5 ml of Isolation Buffer 2. The suspension was layered onto the top of a 
Percoll gradient (26%/40%) in Beckman Ultra-Clear centrifuge tubes and centrifuged for 28 
minutes at 15,500 rpm (41,100×g) in a Beckman Optima L100K ultracentrifuge, bucket rotor 
SW41Ti. Following this centrifugation, either synaptosomes were collected for isolation of 
synaptic mitochondria or nonsynaptic mitochondria were collected. Nonsynaptic 
mitochondria were resuspended in Isolation Buffer 2 and centrifuged for 20 minutes at 
15,500 rpm (41,100×g) in a Beckman Optima L100K ultracentrifuge, bucket rotor SW41Ti. 
The pellet was resuspended in Isolation Buffer 2 and centrifuged again for 20 minutes at 
15,500 rpm (41,100×g) in a Beckman Optima L100K ultracentrifuge, bucket rotor SW41Ti.  
The pellet was collected, resuspended in Isolation Buffer 2, and stored on ice.  This was a 
stock suspension of brain nonsynaptic mitochondria.  Synaptic mitochondria were isolated 
from synaptosomes by nitrogen cavitation using an ice-cold nitrogen cell disruption vessel 
(Parr Instrument Co., Moline, IL; Cat# 4639). Briefly, the synaptosomes obtained following 
Percoll gradient (26%/40%) centrifugation were transferred to a beaker on ice and placed into 
the nitrogen vessel on ice under 1,100 psi for 13 minutes. Then, the ruptured synaptosomes 
were layered onto another discontinuous Percoll gradient (24%/40%) and centrifuged for 28 
minutes at 15,500 rpm (41,100×g) in a Beckman Optima L100K ultracentrifuge, bucket rotor 
SW41Ti. Synaptic mitochondria were resuspended in Isolation Buffer 2 and centrifuged 
twice more for 20 minutes each at 15,500 rpm (41,100×g) in a Beckman Optima, L100K 
ultracentrifuge, bucket rotor SW41Ti exactly as described above for the final two 
centrifugations of nonsynaptic mitochondria preparation. The pellet was collected, 
resuspended in Isolation Buffer 2, and the stock suspension of synaptic mitochondria was 
stored on ice.  The composition of isolation buffers was as follows: Isolation Buffer 1:  225 
mM mannitol, 75 mM sucrose, 10 mM Hepes, pH 7.4 adjusted with KOH, 0.1 mM EGTA; 
Isolation Buffer 2:  395 mM sucrose, 0.1 mM EGTA, 10 mM Hepes, pH 7.4; Percoll Buffer:  
320 mM sucrose, 1 mM EGTA, 10 mM Hepes, pH 7.4. The Percoll gradients were prepared 
using Percoll Buffer with corresponding concentrations of added Percoll.  It was previously 
suggested that BSA may interfere with mHtt binding to mitochondria (Panov et al. 2003). 
Therefore, in our experiments with isolated mitochondria, BSA was omitted from all 
solutions unless otherwise indicated. 
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Preparation of cytosolic fraction 
Cytosolic fraction was collected during the mitochondrial isolation procedure and treated 
with 1µL/mL Benzonase Nuclease (Sigma, St. Louis, MO, USA; Cat# 70664) for 30 minutes 
before being centrifuged at 4°C for 30 minutes at 35,000 rpm (76,000×g) in a Beckman 
Optima L100K ultracentrifuge, rotor Type 90 Ti. The supernate was collected and placed into 
a Spin-X
R
 UF 500 100k MWCO concentrator (Sigma; Cat# 431481) that had been previously 
rinsed with isolation buffer according to the manufacturer’s instructions. The supernate was 
centrifuged at 4°C for 25 minutes at 12,600 rpm (14,900×g) in an Eppendorf 5424R 
centrifuge. Following centrifugation, the supernate was collected from the concentrator, 
stored in a fresh tube on ice, and used on the same day.        
 
Mitochondrial respiration and membrane potential 
Here and in all other experimental procedures, the experimenter was unaware of the animals’ 
group and type of cytosolic fraction applied to mitochondria during experimentation. Our 
study was exploratory. No exclusion criteria were pre-determined and no animals were 
excluded from our study. All experiments were performed during the normal working hours. 
Mitochondrial respiration was measured with a Clark-type oxygen electrode in a tightly 
sealed 0.4 mL thermostated chamber at 37°C under continuous stirring. Experiments were 
performed in the standard incubation medium containing 125 mM KCl, 0.5 mM MgCl2, 3 
mM KH2PO4, 10 mM Hepes, pH 7.4, 10 mM EGTA supplemented with either 3 mM 
pyruvate plus 1 mM malate or 3 mM succinate plus 3 mM glutamate. The slope of the 
oxygen electrode trace corresponds to the respiratory rate. Mitochondrial membrane potential 
was measured in the standard incubation medium at 37°C with a home-made 
tetraphenylphosphonium (TPP
+
) electrode by following TPP
+
 distribution between the 
incubation medium and mitochondria (Kamo et al. 1979). A decrease in external TPP
+
 
concentration corresponds to mitochondrial polarization, whereas an increase in TPP
+
 in the 
incubation medium corresponds to depolarization. The membrane potential was calculated 
using Nernst equation and assuming mitochondrial matrix volume was 0.9µL/mg protein as 
we established for isolated brain mitochondria previously (Brustovetsky et al. 2005). 
 
Mitochondrial Ca
2+
 uptake capacity 
Mitochondrial Ca
2+
 uptake was measured with a home-made miniature Ca
2+
-selective 
electrode in a 0.3 mL chamber at 37°C under continuous stirring. Mitochondrial Ca
2+
 uptake 
was indicated by a decrease in the external Ca
2+
 concentration. The experiments were 
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performed in the standard incubation medium supplemented with 3 mM pyruvate and 1 mM 
malate. As described previously, the incubation medium was also supplemented with 0.1 mM 
ADP and 1M oligomycin (Chalmers and Nicholls 2003). Ca2+ was delivered to 
mitochondria as 10µM CaCl2 pulses. Data were quantified as Ca
2+
 uptake capacity per mg of 
mitochondrial protein.  
 
Mitochondrial ROS production 
Mitochondrial ROS production was measured as H2O2 released from mitochondria and 
monitored by an Amplex Red assay (Molecular Probes, Eugene, OR, USA; Cat# A22188) in 
a 0.4 mL thermostated chamber at 37°C under continuous stirring in the standard incubation 
medium supplemented with either 3 mM pyruvate plus 1 mM malate or 3 mM succinate plus 
3 mM glutamate using a Perkin-Elmer LS 55 luminescence spectrophotometer and 
excitation/emission wavelengths of 550/590 nm as described previously (Votyakova and 
Reynolds 2001).  
 
Immunoblotting  
Brain nonsynaptic mitochondria and cytosolic fractions pretreated with Protease Inhibitor 
Cocktail (Roche, Indianapolis, IN, USA; Cat# 04693124001) were incubated with NuPAGE 
LDS sample buffer (Invitrogen, Carlsbad, CA, USA; Cat# B0007) supplemented with a 
reducing agent at 70°C for 15 min. Tris-acetate gels (3-8%, Invitrogen; Cat# EA0375) were 
used for electrophoresis. Proteins were transferred to a Hybond-ECL nitrocellulose 
membrane (Amersham Biosciences, Piscataway, NJ, USA; Cat# RPN78D) following 
electrophoresis. Blots were incubated at room temperature for 1 h in a blocking solution that 
consisted of either protein-free blocking buffer (Pierce, Rockford, IL, USA; Cat# 37572) plus 
0.15% Triton X-100 or 4% milk, phosphate-buffered saline, pH 7.2, plus 0.15% Triton X-
100. After blocking, blots were incubated with either mouse monoclonal anti-polyQ 1C2 
(mAb 1574, Millipore, Temecula, CA, USA, 1:1000; RRID:AB_94263), mouse monoclonal 
anti-Complex II, 70 kDa subunit (Invitrogen, 1:1000; RRID:AB_1501830), or rabbit 
monoclonal anti-MEK1/2 (Pierce, 1:2000; RRID:AB_10980233). Blots then were incubated 
with goat anti-mouse IgG or goat anti-rabbit IgG (1:25000; RRID:AB_2338504 or 1:20000; 
RRID:AB_2313567, respectively) coupled with horseradish peroxidase (Jackson 
ImmunoResearch Laboratories, West Grove, PA, USA) and developed with Supersignal 
West Pico chemiluminescent reagents (Pierce; Cat# 32106). Molecular mass marker HiMark 
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Pre-stained High Molecular Weight Protein Standard (7µL, Invitrogen; Cat# LC5699) was 
used to determine molecular masses. Band densities were quantified with NIH ImageJ 1.48v 
software (http://rsb.info.nih.gov//ij). 
 
Statistics 
Power analysis was performed using G*Force software version 3.1.9.2 by Franz Faul, 
Universitat Kiel, Germany (Faul et al. 2007) to establish the sample size necessary to detect a 
30% difference between mitochondria treated with a vehicle, WT cytosolic fraction (WT cf) 
and HD cytosolic fraction (HD cf).  We used F test, statistical test ANOVA: repeated 
measures within factors, a priori power analysis, assuming effect size 0.3, alpha 0.05, power 
(1-beta) 0.8, number of groups – 3 (vehicle-, WT cf- and HD cf-treated mitochondria), 
number of measurements – 5, total sample size – 15 (number of all measurements).  Based on 
this power analysis, the number of experiments that gives an 80% likelihood (the accepted 
level in statistical analysis) of detecting 30% difference between three means at the 
significance level of α=0.05 is 5 biological replicates with 3 technical replicates in each 
experiment.  Data are shown as mean ± SD of indicated number of independent experiments. 
Statistical analysis of the experimental results consisted of unpaired t-test or one-way 
ANOVA followed by Bonferroni’s post hoc test if applicable (GraphPad Prism 4.0, 
GraphPad Software Inc., San Diego, CA, USA). No assessment of the normality of data was 
carried out. No test for outliers was conducted and no data points were excluded. 
 
RESULTS 
To answer the questions of whether mHtt can directly damage WT mitochondria and whether 
enrichment of HD mitochondria with exogenous mHtt will result in detectable mitochondrial 
defects, we prepared concentrated cytosolic fraction from brains of WT and YAC128 mice. 
Immunoblotting experiments using mHtt-specific monoclonal antibody 1C2 demonstrated the 
presence of mHtt in cytosolic fraction from YAC128 mice but not from WT animals (Fig. 
1A). Further enrichment of cytosolic fraction with mHtt was achieved by the concentrating 
procedure using a Spin-X
R
 UF 500 100k MWCO concentrator (Sigma) (Fig. 1B). Figure 1E 
depicts a statistical summary of densitometry with immunoblots exemplified by the 
representative blot shown in Fig. 1B. The concentrated mHtt-containing cytosolic fraction 
was applied at 37ºC under gentle shaking to Percoll gradient-purified brain mitochondria 
from WT and YAC128 mice to assess binding of mHtt to brain mitochondria.  Following 5 
minutes of incubation with concentrated mHtt-containing cytosolic fraction, mitochondria 
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were washed out three times with fresh incubation medium. MEK1/2, a cytosolic marker, was 
used to assess the removal of cytosolic components from the mitochondrial suspension. 
Immunoblotting with anti-MEK1/2 antibody confirmed complete removal of cytosolic 
fraction from mitochondria following three washes (Fig. 1C). Immunoblotting with anti-
Complex II, 70 kDa subunit (CII), antibody served as a loading control for mitochondrial 
samples. The incubation of WT mitochondria with concentrated mHtt-containing cytosolic 
fraction from YAC128 mice for 5 minutes resulted in binding of mHtt to mitochondria (Fig. 
1C). We could detect an mHtt band on the blot following incubation of WT mitochondria 
with as little as 20µg of cytosolic protein from YAC128 mice (Fig. 1C). Incubation of WT 
mitochondria with 80μg of cytosolic protein from YAC128 mice resulted in increased 
binding of mHtt to WT mitochondria. Figure 1F depicts a statistical summary of densitometry 
of indicated bands represented by the blot shown in Fig. 1C. The amount of mHtt bound to 
WT mitochondria treated with 80μg of cytosolic protein from YAC128 mice was higher than 
the amount of mHtt associated with brain mitochondria isolated from YAC128 mice (Fig. 
1C). Incubation of brain mitochondria from YAC128 mice for 5 minutes with concentrated 
cytosolic fraction (80µg of protein) from the same animals also increased mHtt binding to 
mitochondria (Fig. 1D). However, exposure of mitochondria to increased amount of cytosolic 
fraction (120µg of protein) and prolonged incubation with cytosolic fraction (15 minutes) did 
not result in further increased mHtt binding to mitochondria (Fig. 1D). Figure 1G shows a 
statistical summary of densitometry of selected bands represented by the blot shown in Fig. 
1D. Based on immunoblotting assessment, in all subsequent experiments we evaluated 
mitochondrial functions following the treatment of brain mitochondria for 5 minutes with 
80μg of protein of concentrated cytosolic fractions produced from brains of WT or YAC128 
mice.        
 
To assess the possible deleterious effect of mHtt on mitochondria, we treated brain 
mitochondria from WT mice with mHtt-containing brain cytosolic fraction from YAC128 
animals and assessed mitochondrial respiration. As a control, we evaluated the effect of 
vehicle (10µL of Isolation Buffer 1) or the effect of concentrated cytosolic fraction from 
brains of WT mice, which contained Htt, but not mHtt. We measured mitochondrial 
respiration with either a combination of Complex I substrates pyruvate (3 mM) and malate (1 
mM), or with the Complex II substrate succinate (3 mM) (Fig. 2). In the case of succinate, 
incubation medium was supplemented with glutamate (3 mM) to stimulate a transaminase 
reaction that facilitates the removal of oxaloacetate, an endogenous inhibitor of succinate 
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dehydrogenase (Wojtczak 1969;Brustovetsky and Dubinsky 2000). We measured basal 
mitochondrial respiration in the presence of substrates (V2), respiration in the presence of 
added cytosolic fraction (Vcf), respiration stimulated by ADP (V3), respiration following ADP 
depletion (V4), and uncoupled respiration in the presence of 2,4-dinitrophenol (2,4-DNP, 
VDNP). Brain mitochondria from WT mice had similar respiratory rates under all conditions 
tested whether mitochondria were exposed to cytosolic fractions from WT or YAC128 
animals (Fig. 2). 
  
In our previous studies, we found no evidence for defects in mitochondria isolated and 
purified from R6/2 and YAC128 mice. Such findings could be due to a decrease in 
mitochondrially bound mHtt during the isolation procedure. Therefore, in the present study, 
we increased the amount of mHtt bound to mitochondria by incubating brain mitochondria 
isolated from YAC128 mice with mHtt-containing cytosolic fraction. In immunoblotting 
experiments, we found increased binding of mHtt to mitochondria from YAC128 mice 
following incubation of these organelles with concentrated cytosolic fraction from the same 
animals (Fig. 1D, G). However, the enrichment with mHtt did not alter respiration of brain 
mitochondria from YAC128 mice (Fig. 3). 
 
In addition to mitochondrial respiration, we also analyzed membrane potential (Δψ) of brain 
mitochondria isolated from WT mice following treatment with cytosolic fractions from either 
YAC128 or WT mice (Fig. 4). Mitochondrial membrane potential was assessed by measuring 
the distribution of the lipophilic cation tetraphenylphosphonium (TPP
+
) across the inner 
mitochondrial membrane. Similar to experiments with respiration, Δψ was measured with 
either a combination of Complex I substrates pyruvate (3 mM) and malate (1 mM), or with 
the Complex II substrate succinate (3 mM) supplemented with glutamate (3 mM). The 
treatment with mHtt- or Htt-containing cytosolic fractions did not significantly change Δψ 
(Fig. 4). Similarly, for each substrate type, the responses to ADP were similar in 
mitochondria exposed to Htt or mHtt (Fig. 4). Consistent with respiration experiments, our 
data with Δψ measurements suggest that neither Htt nor mHtt directly and acutely alter Δψ in 
brain mitochondria.  We also assessed Δψ of brain mitochondria from YAC128 mice 
following enrichment with mHtt and found that Δψ was not altered (Fig. 5). 
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It has been previously reported that ROS production is augmented in mHtt-expressing cells 
compared to control cells (Hands et al. 2011;Chiang et al. 2012). In the current study, we 
used an Amplex Red Assay to evaluate H2O2 production in mitochondria from WT mice 
treated with mHtt-containing cytosolic fraction. ROS generation was notably lower in 
mitochondria that were fueled by pyruvate plus malate compared with mitochondria that were 
incubated with succinate plus glutamate, similar to previously reported data (Pellman et al. 
2015). However, under both conditions, there was no difference in H2O2 generation between 
WT mitochondria that were treated with mHtt- or Htt-containing cytosolic fractions (Fig 6).  
We also assessed H2O2 production in brain mitochondria from YAC128 mice and found that 
mHtt enrichment did not alter H2O2 production in these mitochondria (Fig. 7).       
 
Mitochondrial Ca
2+
 uptake is critical for the clearance of excessive Ca
2+
 from the cytosol, 
thus contributing to the maintenance of Ca
2+
 homeostasis inside of cells and to cell survival 
(Bernardi and Rasola 2007). The amount of Ca
2+
 that can be accumulated by mitochondria is 
limited by induction of the mitochondrial permeability transition pore (Chalmers and 
Nicholls 2003). It has been previously reported that mitochondria from HD animal and cell 
models have decreased Ca
2+ 
uptake capacity compared with mitochondria from WT animals 
and cells (Panov et al. 2002;Milakovic et al. 2006;Lim et al. 2008;Gellerich et al. 2008).  
However, in our previous studies we did not find a decrease in Ca
2+
 uptake capacity in 
mitochondria from HD mice compared to mitochondria from WT mice (Pellman et al. 
2015;Hamilton et al. 2016;Hamilton et al. 2017). In the present study, brain mitochondria 
isolated from WT mice were treated with mHtt- or Htt-containing cytosolic fractions prior to 
assessment of mitochondrial Ca
2+
 uptake capacity (Fig. 8). Mitochondria were fueled with a 
combination of Complex I-linked substrates pyruvate (3 mM) and malate (1 mM), and since 
it was previously proposed that BSA may displace mHtt from the outer mitochondrial 
membrane (OMM), precluding the detection of functional difference between mitochondria 
from HD and WT animals (Panov et al. 2003), BSA was omitted from all media. Of note, in 
our previous study we did not find evidence for mHtt displacement from mitochondria by 
BSA (Pellman et al. 2015). Wild-type mitochondria exposed to mHtt had similar Ca
2+
 uptake 
capacity compared to WT mitochondria exposed to Htt (Fig 8A, B).  In addition, we 
evaluated Ca
2+
 uptake capacity of mitochondria from YAC128 mice following enrichment 
with mHtt (Fig. 8C). Ca
2+
 uptake was monitored under the same conditions that were 
described for experiments with WT mitochondria (Fig. 8A). The Ca
2+
 uptake capacity of 
brain mitochondria from YAC128 mice was not changed by mHtt enrichment (Fig. 8D).   
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Using synaptic mitochondria isolated from both WT and YAC128 mice and exposed to a 
vehicle or concentrated mHtt-containing cytosolic fraction, we measured respiration, 
membrane potential, ROS production and Ca
2+
 uptake capacity and obtained results similar to 
those produced with nonsynaptic mitochondria (Suppl. Figs. 1-4) 
 
DISCUSSION 
The possible involvement of mitochondrial dysfunction in the pathogenesis of HD has been 
investigated since before the causative mutation in HD was even identified (Brennan, Jr. et 
al. 1985). However, the results from studies of mitochondrial functions in HD have been 
contradictory, and it remains unclear whether mHtt expression results in mitochondrial 
defects and whether these mitochondrial defects contribute to HD pathogenesis (Brustovetsky 
2016). Differences in experimental models of HD used in these studies as well as the wide 
array of experimental techniques applied by different investigators may account for some of 
the discrepancies in experimental results. In our previous work, we assessed mitochondrial 
functions in different mouse models of HD and demonstrated that nonsynaptic and synaptic 
mitochondria isolated from either whole brains of YAC128 and R6/2 mice or from striata of 
YAC128 mice had similar respiratory rates, ROS production, and Ca
2+
 uptake capacity 
compared to mitochondria from WT animals (Pellman et al. 2015;Hamilton et al. 
2015;Hamilton et al. 2016;Hamilton et al. 2017). Consistent with our results produced with 
isolated mitochondria, experiments with cultured striatal neurons derived from YAC128 and 
R6/2 mice and corresponding WT mice indicated that oxidative metabolism and 
mitochondrial Ca
2+
 handling were not altered in neurons expressing mHtt compared to WT 
neurons (Pellman et al. 2015;Hamilton et al. 2015;Hamilton et al. 2016). Despite the use of 
different animal models and experimental techniques, these studies consistently demonstrated 
the lack of mitochondrial dysfunction in HD samples, arguing against this mechanism as a 
contributing factor in HD pathogenesis. 
 
In the present study, we evaluated whether the direct application of mHtt to brain 
mitochondria from WT mice could alter respiration, membrane potential, ROS production, 
and Ca
2+
 uptake capacity. If mitochondrial dysfunction does, indeed, contribute to HD 
pathogenesis, such dysfunction could be incited by two mechanisms. Either mHtt indirectly 
inhibits normal mitochondrial functions by interfering with processes such as transcription 
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which ultimately results in mitochondrial aberrations (Chiang et al. 2012), or mHtt directly 
damages mitochondria through mechanisms that may include interacting with proteins on the 
OMM (Yano et al. 2014). Our current study tested the latter hypothesis by evaluating the 
effect of acutely applied mHtt to mitochondria from WT mice.  
In an earlier study, Panov et al. found that acute treatment of rat liver mitochondria and 
human lymphoblast mitochondria with the glutathione S-transferase (GST) fusion protein 
containing a pathological-length polyQ stretch induced more rapid mitochondrial 
depolarization in response to Ca
2+
 compared with mitochondria incubated with fusion 
proteins containing a shorter polyQ stretch (Panov et al. 2003). Soon after, Puranam et al. 
reported that pathologic-length polyQ-GST fusion protein directly inhibited ADP-dependent 
(State 3) respiration and increased the production of ROS in mitochondria isolated from 
mouse liver (Puranam et al. 2006). In these studies, the authors used a polyQ-GST fusion 
protein containing a pathological-length polyQ stretch (Panov et al. 2002;Puranam et al. 
2006). The use of this artificial construct potentially could lead to artifacts.  In our study, we 
treated isolated brain mitochondria with cytosolic fraction prepared from the brains of 
YAC128 mice and containing natural human full-length mHtt, which is more physiologically 
relevant. The lack of direct and acute mHtt effect on brain mitochondria, described in the 
current paper, is consistent with our previous reports, indicating the lack of defects both in 
brain mitochondria isolated from HD mice (R6/2 and YAC128) and in mitochondria of 
cultured neurons from these animals (Pellman et al. 2015;Hamilton et al. 2015;Hamilton et 
al. 2016;Hamilton et al. 2017).  
 
The use of isolated mitochondria as a model system allows for the examination of 
mitochondrial functions under well-defined conditions. Despite this advantage, there are 
obvious limitations of using isolated mitochondria. Although, this model allows for the 
design of straightforward experiments to answer simple questions, it does not and is not 
intended to completely recapitulate in vivo conditions.  Isolated mitochondria are removed 
from their natural environment while being subjected to a harsh isolation procedure. 
Therefore, it is conceivable that some proteins associated with the OMM could be lost during 
the isolation procedure. We and others have previously shown that mHtt remains attached to 
the OMM during mitochondrial isolation (Choo et al. 2004;Orr et al. 2008;Pellman et al. 
2015;Hamilton et al. 2015). However, it is unclear how much mHtt associated with 
mitochondria in vivo remains attached to the OMM following the isolation procedure. This 
consideration raises the possibility that, if mHtt does directly interfere with mitochondrial 
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functions, then failure to observe such mitochondrial defects in our previous studies may 
have been due to dissociation of mHtt from the OMM and partial loss of mHtt during 
mitochondrial isolation. Additionally, considering the lack of dysfunction in WT 
mitochondria acutely treated with cytosolic fraction from YAC128 mice, one can hypothesize 
that mitochondria from YAC128 mice may possess some inherent characteristics that make 
them susceptible to the deleterious effects of mHtt. Consequently, in the current study we 
analyzed the functions of brain mitochondria from YAC128 mice following enrichment with 
mHtt. However, despite our stringent efforts, brain mitochondria derived from YAC128 mice 
and enriched with mHtt did not demonstrate alterations in respiration, membrane potential, 
ROS production, and Ca
2+
 uptake capacity compared to mitochondria from YAC128 mice 
treated with Htt-containing cytosolic fraction.     
  
In an elegant study, Yano et al. (2014) demonstrated an mHtt-induced decrease in 
mitochondrial protein import (Yano et al. 2014). However, in that study Yano et al. did not 
investigate whether inhibition of protein import led to decreased expression of nuclear-
encoded mitochondrial proteins. We previously assessed the level of expression of randomly 
chosen nuclear-encoded proteins in mitochondria of WT and HD mice and did not find any 
difference (Hamilton et al. 2015;Hamilton et al. 2016). Consistent with these previous 
studies, the lack of altered protein expression in mitochondria from WT and HD mice and 
striatal cells has been reported by other groups (Orr et al. 2008; Milakovic and Johnson 
2005). Moreover, despite reporting inhibition of mitochondrial protein import, Yano et al. did 
not find any sign of mitochondrial respiratory dysfunction (Yano et al. 2014), which is 
consistent with our findings (Hamilton et al. 2015;Hamilton et al. 2016). In the current study, 
based on our previously published results and data from other groups, we decided not to 
investigate mitochondrial protein import further. 
 
Overall, our current data with mHtt acutely applied to isolated brain mitochondria and 
previously published data with whole-brain and striatal mitochondria do not provide evidence 
for mHtt-induced mitochondrial respiratory deficiency, abnormal ROS production, and 
defects in mitochondrial Ca
2+
 handling (Pellman et al. 2015;Hamilton et al. 2015;Hamilton et 
al. 2016;Hamilton et al. 2017). The lack of alterations in respiration, membrane potential, 
ROS production, and Ca
2+
 uptake by brain mitochondria acutely exposed to mHtt suggests 
that mHtt does not directly impair mitochondria. Consequently, mHtt neurotoxicity most 
likely could be mediated by mechanisms unrelated to overt mitochondrial defects, but linked 
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to the events such as oxidative stress associated with elevated NAD(P)H oxidase activity 
(Brennan et al. 2009;Tarafdar and Pula 2018), alterations in cholesterol metabolism 
(Trushina et al. 2014), aberrant mitochondrial trafficking (Trushina et al. 2004;Shirendeb et 
al. 2012), or metabolic reprograming to preferential oxidation of fatty acids (Polyzos et al. 
2019). Therefore, it is conceivable that mitochondrial impairment, if it is involved in HD 
pathology, may exist as a secondary process downstream of mHtt-induced deleterious 
changes in other cellular functions.           
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Figure Legends 
Figure 1. Detection of mHtt bound to WT and YAC128 nonsynaptic mitochondria 
following incubation with brain cytosolic fraction from YAC128 mice. In A, mHtt was 
detected with mHtt-specific monoclonal antibody 1C2 as a single 350 kDa band in brain 
cytosolic fraction from YAC128 but not WT mice. Here and in other panels (B-D), MEK1/2 
was used as a cytosolic marker, indicating the absence of cytosolic contamination in 
mitochondrial fraction, and Complex II, 70 kDa subunit (CII) was used as a mitochondrial 
marker as control for loading. In B, mHtt enrichment in brain cytosolic fraction from 
YAC128 mice after concentrating with Spin-X
R
 UF 500 100k MWCO concentrators (Sigma). 
In C, mHtt presence in brain mitochondrial fraction from YAC128 mice (YAC) and binding 
of mHtt to WT mitochondria. WT mitochondria were incubated with either 20 or 80µg of 
protein of concentrated YAC128 brain cytosolic fraction for 5 minutes and then washed out 
three times. In D, enrichment of YAC128 mitochondria with mHtt following incubation with 
either 80 or 120µg of protein of concentrated YAC128 brain cytosolic fraction for 5 or 15 
minutes.  In E, the statistical summary of densitometry of mHtt bands obtained with 1C2 
antibody in cytosolic fractions before and after concentrating procedure. Data are mean±SD, 
n=4 separate independent mitochondrial preparations, **p<0.01 comparing the level of mHtt 
in YAC128 cytosolic fraction before and after concentrating procedure. In F and G, the 
statistical summaries of densitometry of mHtt bands obtained with 1C2 antibody in 
mitochondrial samples before and after treatment with concentrated mHtt-containing 
cytosolic fraction. Mutant Htt band intensities were normalized to respective CII signals. 
Data are mean±SD, n=4 separate independent mitochondrial preparations, *p<0.05 
comparing the level of mHtt bound to WT mitochondria treated with 80µg of concentrated 
mHtt-containing cytosolic fraction and to untreated YAC128 mitochondria. **p<0.01 
comparing the level of mHtt bound to WT mitochondria treated with either 20 or 80µg of 
concentrated mHtt-containing cytosolic fraction (F); **p<0.01 comparing the level of mHtt 
bound to untreated YAC128 mitochondria and YAC128 mitochondria treated with either 80 
or 120µg of concentrated mHtt-containing cytosolic fraction (G).         
 
Figure 2. Respiratory activity of brain nonsynaptic mitochondria isolated from WT 
mice following acute application of brain cytosolic fractions from WT or YAC128 
animals. In A and C, representative traces of oxygen consumption by mitochondria treated 
with either vehicle (green traces), WT concentrated cytosolic fraction (WT cf, blue traces), or 
YAC128 concentrated cytosolic fraction (HD cf, red traces). Where indicated, ADP (250µM 
in A, 150µM in C), 2,4-dinitrophenol (2,4-DNP, 60µM), and vehicle (10µL of Isolation 
Medium 1), or WT or YAC128 cytosolic fractions (WT cf or HD cf, 80µg of protein) were 
added to mitochondria. The incubation medium was supplemented with either 3 mM 
pyruvate (pyr) and 1 mM malate (mal) (A) or 3 mM succinate (succ) and 3 mM glutamate 
(glu) (C). In B and D, the statistical summary of respiratory rates of mitochondria incubated 
with either pyruvate plus malate (B) or succinate plus glutamate (D). Data are mean±SD, n=5 
separate independent mitochondrial preparations.      
 
Figure 3. Respiratory activity of brain nonsynaptic mitochondria isolated from YAC128 
mice following acute application of brain cytosolic fractions from either WT or YAC128 
animals. In A and C, representative traces of oxygen consumption by mitochondria treated 
with either WT concentrated cytosolic fraction (WT cf, blue traces) or YAC128 concentrated 
cytosolic fraction (HD cf, red traces). Where indicated, ADP (250µM in A, 150µM in C), 
2,4-dinitrophenol (2,4-DNP, 60µM), and WT or YAC128 cytosolic fractions (WT cf or HD 
cf, 80µg of protein) were added to mitochondria. The incubation medium was supplemented 
with either 3 mM pyruvate (pyr) and 1 mM malate (mal) (A) or 3 mM succinate (succ) and 3 
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mM glutamate (glu) (C). In B and D, the statistical summary of respiratory rates of 
mitochondria incubated with either pyruvate plus malate (B) or succinate plus glutamate (D). 
Data are mean±SD, n=5 separate independent mitochondrial preparations.   
 
Figure 4. Membrane potential of brain nonsynaptic mitochondria isolated from WT 
mice following acute application of brain cytosolic fractions from WT or YAC128 
animals. In A-C and E-G, representative TPP
+
 traces indicative of changes in mitochondrial 
membrane potential (Δψ) in response to 250µM ADP and 60µM 2,4-dinitrophenol following 
addition of vehicle (10µL of Isolation Medium 1, green traces) (A, E), or cytosolic fractions 
from either WT (WT cf, blue traces) (B, F) or YAC128 (HD cf, red traces) (C, G) mice. In 
A-C, the standard incubation medium was supplemented with 3 mM pyruvate (pyr) and 1 
mM malate (mal). In E-G, the standard incubation medium was supplemented with 3 mM 
succinate (succ) and 3 mM glutamate (glu). In D and H, statistical summaries of 
mitochondrial membrane potential measurements taken 30 seconds prior to ADP addition in 
the standard incubation medium containing pyruvate plus malate or succinate plus glutamate, 
respectively. Data are mean±SD, n=4 separate independent mitochondrial preparations.  
 
Figure 5. Membrane potential of brain nonsynaptic mitochondria isolated from 
YAC128 mice following acute application of brain cytosolic fractions from WT and 
YAC128 animals. In A-D, representative TPP
+
 traces indicative of changes in mitochondrial 
membrane potential (Δψ) in response to 250µM ADP and 60µM 2,4-dinitrophenol following 
addition of brain cytosolic fractions from either WT (WT cf, blue traces) (A, C), or YAC128 
(HD cf, red traces) (B, D) mice. In A-B, the standard incubation medium was supplemented 
with 3 mM pyruvate (pyr) and 1 mM malate (mal). In C-D, the standard incubation medium 
was supplemented with 3 mM succinate (succ) and 3 mM glutamate (glu). In E and F, 
statistical summaries of mitochondrial membrane potential measured 30 seconds prior to 
ADP addition in the standard incubation medium containing pyruvate plus malate or 
succinate plus glutamate, respectively. Data are mean±SD, n=4 separate independent 
mitochondrial preparations.  
 
Figure 6. H2O2 production by brain nonsynaptic mitochondria isolated from WT mice 
following acute application of brain cytosolic fractions from WT or YAC128 animals. In 
A and B, H2O2 production by brain mitochondria isolated from WT mice before and after the 
addition of vehicle (10µL of Isolation Medium 1, green traces) or brain cytosolic fractions 
from either WT (WT cf, blue traces) or YAC128 (HD cf, red traces) mice. H2O2 production 
was assessed using an Amplex Red assay (Molecular Probes) with mitochondria incubated in 
the standard incubation medium supplemented with either 3 mM pyruvate (pyr) and 1 mM 
malate (mal) (A) or 3 mM succinate (succ) and 3 mM glutamate (glu) (B). In C and D, 
statistical summaries of mitochondrial H2O2 production rate. Data are mean±SD, n=4 
separate independent mitochondrial preparations.  
 
Figure 7. H2O2 production by brain nonsynaptic mitochondria isolated from YAC128 
mice following acute application of brain cytosolic fractions from WT or YAC128 
animals. In A and B, H2O2 production by brain mitochondria isolated from YAC128 mice 
before and after the addition of brain cytosolic fractions from either WT (WT cf, blue traces) 
or YAC128 (HD cf, red traces) mice. H2O2 production was assessed using an Amplex Red 
assay (Molecular Probes) with mitochondria incubated in the standard incubation medium 
supplemented with either 3 mM pyruvate (pyr) and 1 mM malate (mal) (A) or 3 mM 
succinate (succ) and 3 mM glutamate (glu) (B). In C and D, statistical summaries of 
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mitochondrial H2O2 production rate. Data are mean±SD, n=4 separate independent 
mitochondrial preparations.  
 
Figure 8. Ca
2+
 uptake capacity of brain nonsynaptic mitochondria isolated from WT 
and YAC128 mice following acute application of brain cytosolic fractions from WT or 
YAC128 animals. In A and C, Ca
2+
 uptake capacity of brain mitochondria from either WT 
or YAC128 mice, respectively, following addition of cytosolic fractions from either WT (WT 
cf, blue traces) or YAC128 (HD cf, red traces) mice. The standard incubation medium was 
supplemented with 0.1 mM ADP and 1M oligomycin (Chalmers and Nicholls 2003).  In A, 
control with vehicle (10µL of Isolation Medium 1, green trace) is shown. Ca
2+
 uptake was 
assessed with a miniature Ca
2+
-selective electrode as a decrease in Ca
2+
 concentration in the 
standard incubation medium supplemented with 3 mM pyruvate (pyr) and 1 mM malate 
(mal). In B and D, statistical summaries of Ca
2+
 uptake capacity of brain mitochondria from 
WT and YAC128 mice, respectively. Data are mean±SD, n=5 separate independent 
mitochondrial preparations.  
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